Avricore Expands Health Testing in Rexall Pharmacies
Company Announcements

Avricore Expands Health Testing in Rexall Pharmacies

Avricore Health (TSE:AVCR) has released an update.

Avricore Health is expanding its HealthTab point-of-care testing platform through a new agreement with Rexall Pharmacy Group, aiming to deploy the technology in at least 20 more locations in Alberta and Ontario. This expansion is expected to empower pharmacists and patients with quick access to health data for better treatment plans and outcomes. HealthTab’s network is designed to facilitate more active pharmacist roles in primary care and provide patients with immediate test results and health insights.

For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAvricore Health Achieves First Net Profitability
TipRanks Auto-Generated NewsdeskAvricore Health Posts Q1 Profit and Asset Growth
TipRanks Canadian Auto-Generated NewsdeskAvricore Health Celebrates First Profitable Quarter
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!